ArticleResearch square2025

Empiric Azithromycin in COVID-19 Impacts the Respiratory Microbiome and Antimicrobial Resistome without Anti-inflammatory Benefit.

Charles Langelier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.